Immunotherapy for infectious diseases represents a cutting-edge approach to combatting microbial pathogens by harnessing the body's immune system. Unlike traditional antimicrobial agents, which directly target pathogens, immunotherapy focuses on bolstering the host's immune response to better eliminate invading microbes. This strategy involves various interventions, including vaccines, monoclonal antibodies, and immune modulators, designed to enhance the body's ability to recognize and neutralize infectious agents. For instance, vaccines stimulate the production of pathogen-specific antibodies and memory T-cells, providing long-term protection against future infections. Similarly, monoclonal antibodies can directly target and neutralize microbial toxins or virulence factors, mitigating disease severity. By leveraging the power of immunotherapy, researchers aim to develop novel strategies for preventing and treating a wide range of infectious diseases, potentially revolutionizing the field of infectious disease management.
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Changing population immunity to COVID-19 in the context of infection, vaccination, and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : From bench to preclinical evaluation: LL-37-derived peptides for combating orthopedic infections
Vincenzo Pennone, IRCCS Galeazzi Sant’Ambrogio Hospital, Italy
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Personalized and precision medicine (PPM) as a unique healthcare model to se-cure the human healthcare, wellness and biosafety through the view of public health, network driven healthcare services and lifestyle management
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation